Seattle Genetics (SGEN) PT Raised to $77 at H.C. Wainwright

February 7, 2018 7:24 AM EST Send to a Friend
H.C. Wainwright raised its price target on Seattle Genetics (NASDAQ: SGEN) to $77.00 (from $75.00) while maintaining a Buy rating.Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login